The CDMO/CRDMO outsourcing pipeline, rupee weakness supporting export realisations, continued demand for oncology, peptides and injectables, and upcoming patent expiries could provide further growth opportunities.
Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.